MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4067/s0034-98872026000200201

Медицинская библиотека · Revista medica de Chile · 2026

[Hematologic Monitoring During Long-Term Clozapine Treatment: Retrospective Data from Chilean Patients with Schizophrenia].

Olguín Sepúlveda Pablo, Acuña Pérez Vanessa, Ramírez Parra Javier, Cavieres Fernández Álvaro

СтатьяНаблюдательное исследованиеАннотация на английскомПеревод в очереди

Аннотация

UNLABELLED: Clozapine is the most effective treatment for resistant schizophrenia, although its use is limited by the risk of hematological adverse effects, especially neutropenia. However, there are scarce data from populations in our environment, especially from long-term follow-up.

AIM: To determine the incidence of hematological alterations in patients with schizophrenia under chronic treatment with clozapine at the Hospital del Salvador de Valparaíso.

METHODS

Retrospective observational study that analyzed 31,430 hemograms of 358 patients treated with clozapine at the Hospital del Salvador de Valparaíso between 2002 and 2020. The presence of leukocytosis, eosinophilia, anemia, thrombocytosis, thrombocytopenia and neutropenia was evaluated according to MINSAL criteria. Duration, recurrence and distribution by sex and age and frequency of alterations in relation to chronic use of the drug were described.

RESULTS

The most frequent alterations were leukocytosis (74%), eosinophilia (62%) and anemia (32%). The least common were thrombocytopenia (17%), thrombocytosis (17%) and neutropenia (6.2%). Most events occurred after the first year of treatment, with high recurrence in leukocytosis (79%) and eosinophilia (69%). Neutropenia was predominantly mild and transient, with no severe cases after the first year. Differences by sex were observed in the prevalence of anemia (more frequent in women), but not in other alterations.

CONCLUSIONS

Hematological alterations in Chilean patients on chronic clozapine treatment are frequent and recurrent but mostly benign. The low incidence of severe neutropenia, especially after one year of treatment, supports the revision of current monitoring protocols, which could be limiting access to this drug, but more data from the local population are required to guide clinical and health policy decisions in the region.

Для цитирования: Olguín Sepúlveda Pablo, Acuña Pérez Vanessa, Ramírez Parra Javier, Cavieres Fernández Álvaro. [Hematologic Monitoring During Long-Term Clozapine Treatment: Retrospective Data from Chilean Patients with Schizophrenia].. Revista medica de Chile. 2026. DOI: 10.4067/s0034-98872026000200201.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.